Renal-Limited Thrombotic Microangiopathy due to Bevacizumab Therapy for Metastatic Colorectal Cancer: A Case Report

被引：9

作者：

Toriu, Naoya ^{[1
,2
]}

Sekine, Akinari ^{[1
,2
]}

Mizuno, Hiroki ^{[1
,2
]}

Hasegawa, Eiko ^{[1
,2
]}

Yamanouchi, Masayuki ^{[1
,2
]}

Hiramatsu, Rikako ^{[1
,2
]}

Hayami, Noriko ^{[1
,2
]}

Hoshino, Junichi ^{[1
,2
]}

Kawada, Masahiro ^{[1
,2
]}

Suwabe, Tatsuya ^{[1
,2
]}

Sumida, Keiichi ^{[1
,2
]}

Sawa, Naoki ^{[1
,2
]}

Takaichi, Kenmei ^{[1
,2
,4
]}

Ohashi, Kenichi ^{[3
,6
]}

Fujii, Takeshi ^{[3
]}

Matoba, Shuichiro ^{[5
]}

Ubara, Yoshifumi ^{[1
,2
,4
]}

机构：

[1] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan

[2] Toranomon Gen Hosp, Dept Rheumatol, Tokyo, Japan

[3] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan

[4] Okinaka Mem Inst Med Res, Tokyo, Japan

[5] Toranomon Gen Hosp, Colorectal Surg Unit, Dept Digest Surg, Tokyo, Japan

[6] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa, Japan

来源：

CASE REPORTS IN ONCOLOGY | 2019年 / 12卷 / 02期

关键词：

Thrombotic microangiopathy; Bevacizumab; Nephrotic syndrome; Colorectal cancer; KIDNEY-DISEASES; VEGF;

D O I：

10.1159/000500716

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

An 88-year-old Japanese man received bevacizumab for colorectal cancer with liver and peritoneal metastasis, during which nephrotic range proteinuria occurred (7.66 g/day). Renal biopsy showed endothelial damage with subendothelial swelling and a double contour of the glomerular basement membrane, which indicated a diagnosis of thrombotic microangiopathy (TMA). After bevacizumab was stopped, proteinuria decreased to 1 g/day. During the clinical course, this patient had no extrarenal manifestations. This case suggests that renal injury induced by bevacizumab is characterized by nephrotic range proteinuria and histological TMA, and is a renal-limited condition that differs from systemic TMA related to thrombotic thrombocytopenic purpura.

引用

页码：391 / 400

页数：10

共 50 条

[41] Bevacizumab in the therapy for refractory metastatic colorectal cancer
Mulcahy, Mary F.
BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 53 - 59
[42] HITTING AN UNINTENDED TARGET: THROMBOTIC MICROANGIOPATHY AS A RESULT OF BEVACIZUMAB ADMINISTRATION IN METASTATIC RENAL CELL CARCINOMA
Thigpen, S. C.
Saxon, J.
Elkins, S.
Dreisbach, A.
Hamilton, D.
JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (02) : 521 - 521
[43] Cisplatin/dexamethasone/gemcitabineRenal-limited thrombotic microangiopathy: case report
Reactions Weekly, 2021, 1859 (1) : 99 - 99
[44] Interferon-αRenal failure and thrombotic microangiopathy: case report
Reactions Weekly, 1997, 667 (1) : 10 - 10
[45] Case Report: Scleroderma Renal Crisis Presenting as Thrombotic Microangiopathy
Ugur, Mehmet Can
Ekinci, Ferhat
Karadeniz, Tugba
Gram, Elif
Colak, Hulya
Ceylan, Cengiz
Akar, Harun
TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2016, 25 : 71 - 74
[46] Monoclonal Gammopathy of Renal Significance and Thrombotic Microangiopathy: A Case Report
Ventura, Sofia
Cabral, Raquel
Viveiros, Carolina
Santos, Mariana S.
Esteves, Joao
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
[47] A CASE REPORT OF ELTROMBOPAG ASSOCIATED RENAL LIMITED THROMBOTIC MICROANGIOPATHY LEADING TO ACUTE RENAL FAILURE MANAGED WITH PLASMA EXCHANGE
Bali, P.
Hidayati, L.
Nelson, C.
Dow, C.
NEPHROLOGY, 2020, 25 : 42 - 42
[48] CarfilzomibFirst report of renal thrombotic microangiopathy, podocytopathy and malignant hypertension: case report
Reactions Weekly, 2014, 1532 (1) : 64 - 64
[49] Thrombotic microangiopathy due to Bothrops erythromelas: a case report in Northeast Brazil
Brasileiro Mota, Sandra Mara
Moura Moreira Albuquerque, Polianna Lemos
da Silva Junior, Geraldo Bezerra
Daher, Elizabeth De Francesco
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2020, 62 : 1 - 5
[50] Adverse effects of bevacizumab in metastatic colorectal cancer : a case report and literature review
Willems, E.
Gerne, L.
George, C.
D'Hondt, M.
ACTA GASTRO-ENTEROLOGICA BELGICA, 2019, 82 (02) : 322 - 325

← 1 2 3 4 5 →